Emcure Pharma Q2 FY27 Results: Revenue Up 24.3% as International Business Surges and Guidance Rises
Why the Emcure FY27 guidance matters: revenue growth above 20%, margin expansion and a net cash target, with the debt and execution risks behind it.
Tag: Emcure Pharma Q2 FY27 results
Read More